相关实验视频

Updated: Jun 21, 2025

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

在多发性骨髓瘤中使用佐勒龙酸后, γδT 细胞和骨再吸收标记物的动态变化:一项前性研究

Chao-Hung Wei¹, Yeu-Chin Chen², Shang-Yi Huang³

¹Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan.

Journal of the Formosan Medical Association = Taiwan yi zhi

|July 14, 2024

概括

在多发性骨髓瘤 (MM) 患者中,龙酸 (ZOA) 治疗的玛三角形T细胞 (γδT细胞) 的持续增加模式表明预后不佳. 在这些患者中,乙烯酸还降低了骨质再吸收标记.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

多发性骨髓瘤 (MM) 是一种血性恶性瘤,其特征是不受控制的血细胞增殖.
佐勒多尼酸 (ZOA) 是一种双酸盐,通常用于MM以抑制骨再吸收.
马三角形T细胞 (γδT细胞) 在免疫监测和瘤反应中发挥作用.

研究的目的:

在接受初始ZOA治疗的MM患者中,研究γδT细胞和骨再吸收标记物 (uNTX) 的动态变化.
为了确定 γδT 细胞动态和患者结果之间的潜在相关性.

主要方法:

对接受初始ZOA治疗的35名MM患者 (25名新诊断) 的前性评估.
在ZOA输液前和后的多个时间点监测周围血液的γδT细胞百分比.
测量尿液中的N-telopeptide I型原蛋白 (uNTX) 水平,同时进行γδT细胞评估.

主要成果:

观察到三种不同的 γδT 细胞动态模式:波动,持续增加和持续减少.
在新诊断的MM患者中,不断增加的γδT细胞模式与较短的整体存活时间 (4.7与92.9个月,p=0.037) 有显著的关联.
佐勒多尼酸治疗导致uNTX水平显著下降,这表明骨再吸收减少.

结论:

在MM患者中ZOA启动后,出现了不同的γδT细胞动态模式.
一个不断增长的 γδT 细胞模式是MM中预后不佳的潜在生物标志物.
这些发现突显了γδT细胞,ZOA和MM瘤微环境之间的复杂相互作用,需要进一步调查.

关键词:

多发性骨髓瘤是一种多发性骨髓瘤.这是T-淋巴细胞.佐勒多尼酸是一种酸.

更多相关视频

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

相关概念视频

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...